Accelerate Diagnostics Operating Income 2010-2024 | AXDX

Accelerate Diagnostics operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Accelerate Diagnostics Operating Income 2010-2024 | AXDX

Accelerate Diagnostics operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$233.5B
Intuitive Surgical (ISRG)$174.1B
Alcon (ALC)$48.6B
IQVIA Holdings (IQV)$43.5B
Edwards Lifesciences (EW)$41.3B
IDEXX Laboratories (IDXX)$41.2B
DexCom (DXCM)$27.9B
STERIS (STE)$24.1B
SONOVA HOLDING (SONVY)$21.4B
Waters (WAT)$19.3B
Hologic (HOLX)$18.8B
Fresenius Medical Care AG KGaA (FMS)$12.4B
Sysmex ADR (SSMXY)$12.4B
Teleflex (TFX)$11.6B
Globus Medical (GMED)$9.4B
Penumbra (PEN)$7.3B
Glaukos (GKOS)$6.9B
Masimo (MASI)$6B
TransMedics (TMDX)$5.1B
Integer Holdings (ITGR)$4.3B
PROCEPT BioRobotics (PRCT)$4.2B
Tandem Diabetes Care (TNDM)$2.9B
Inari Medical (NARI)$2.7B
LivaNova (LIVN)$2.6B
Veracyte (VCYT)$2.5B
Nihon Kohden (NHNKY)$2.5B
Elekta AB (EKTAY)$2.5B
RxSight (RXST)$2B
Integra LifeSciences Holdings (IART)$1.4B
Pulse Biosciences (PLSE)$1.1B